TrialJournal of hematology & oncology2009

Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.

Azra Raza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.